Senior Leadership

TAI 310x206

Tahamtan Ahmadi, M.D., Ph.D.

Iranian-German (US Citizen)
Senior Vice President Oncology and Translational Medicine

Dr. Ahmadi joined Genmab in 2017. He holds an M.D. from the University of Cologne (Germany) and a Ph.D. from the University of Freiburg (Germany) and has expertise in translational research, strategic product development, global regulatory submissions and clinical development. Prior to joining Genmab Dr. Ahmadi was Head of Experimental Medicine and Early Development Oncology at Janssen and a member of the Senior Leadership Team for Oncology. During his time at Janssen he led the global development of daratumumab including clinical R&D and medical affairs strategy across indications and was instrumental in the clinical development and initial FDA NDA submission for Ibrutinib. Prior to joining Janssen, Dr. Ahmadi was a faculty member of the Dept of Hematology and Oncology at the University of Pennsylvania. Dr. Ahmadi is an author on a number of scientific articles, which have been published in journals such as NEJM, Lancet, JCO and Blood among others.  

Back To Senior Leadership